281 related articles for article (PubMed ID: 21750899)
1. Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
Koning JP; Vehof J; Burger H; Wilffert B; Al Hadithy A; Alizadeh B; van Harten PN; Snieder H;
Psychopharmacology (Berl); 2012 Feb; 219(3):727-36. PubMed ID: 21750899
[TBL] [Abstract][Full Text] [Related]
2. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
[TBL] [Abstract][Full Text] [Related]
3. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
5. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
Hori H; Ohmori O; Shinkai T; Kojima H; Nakamura J
Am J Med Genet; 2001 Dec; 105(8):774-8. PubMed ID: 11803529
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment.
Dolzan V; Plesnicar BK; Serretti A; Mandelli L; Zalar B; Koprivsek J; Breskvar K
Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):809-15. PubMed ID: 17455212
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study.
Bakker PR; Al Hadithy AF; Amin N; van Duijn CM; van Os J; van Harten PN
PLoS One; 2012; 7(12):e50970. PubMed ID: 23226551
[TBL] [Abstract][Full Text] [Related]
8. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
[TBL] [Abstract][Full Text] [Related]
9. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Zai CC; Romano-Silva MA; Hwang R; Zai GC; Deluca V; Müller DJ; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
Schizophr Res; 2008 Dec; 106(2-3):248-52. PubMed ID: 18838251
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Garcia-Barceló MM; Lam LC; Ungvari GS; Lam VK; Tang WK
J Neural Transm (Vienna); 2001; 108(6):671-7. PubMed ID: 11478419
[TBL] [Abstract][Full Text] [Related]
11. Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia.
Mo GH; Lai IC; Wang YC; Chen JY; Lin CY; Chen TT; Chen ML; Liou YJ; Liao DL; Bai YM; Lin CC
Schizophr Res; 2007 Dec; 97(1-3):302-4. PubMed ID: 17669630
[No Abstract] [Full Text] [Related]
12. The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia.
Liou YJ; Lai IC; Liao DL; Chen JY; Lin CC; Lin CY; Chen CM; Bai YM; Chen TT; Wang YC
Schizophr Res; 2006 Sep; 86(1-3):323-5. PubMed ID: 16769201
[No Abstract] [Full Text] [Related]
13. Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.
Ozdemir V; Basile VS; Masellis M; Kennedy JL
J Biochem Biophys Methods; 2001 Jan; 47(1-2):151-7. PubMed ID: 11179771
[TBL] [Abstract][Full Text] [Related]
14. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
[TBL] [Abstract][Full Text] [Related]
15. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Gunes A; Scordo MG; Jaanson P; Dahl ML
Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
[TBL] [Abstract][Full Text] [Related]
16. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia.
Levchenko A; Vyalova N; Pozhidaev IV; Boiko AS; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM; Ivanova SA
Hum Psychopharmacol; 2019 Jan; 34(1):e2685. PubMed ID: 30623492
[TBL] [Abstract][Full Text] [Related]
17. Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.
Bakker PR; Bakker E; Amin N; van Duijn CM; van Os J; van Harten PN
PLoS One; 2012; 7(5):e36561. PubMed ID: 22615781
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes.
Zhang XR; Zhang ZJ; Zhu RX; Yuan YG; Jenkins TA; Reynolds GP
Pharmacogenomics; 2011 Aug; 12(8):1127-36. PubMed ID: 21749219
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients.
Zai CC; De Luca V; Hwang RW; Voineskos A; Müller DJ; Remington G; Kennedy JL
Mol Psychiatry; 2007 Sep; 12(9):794-5. PubMed ID: 17767146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
